|
End-of-day quote
Other stock markets
|
||
| - MKD | - |
|
| 30/25/30 | Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| 30/25/30 | Alkaloid AD Skopje Reports Earnings Results for the First Quarter Ended March 31, 2025 | CI |
More news
More press releases
| Manager | Title | Age | Since |
|---|---|---|---|
Zhivko Mukaetov
CEO | Chief Executive Officer | 51 | 01/01/2007 |
| Director of Finance/CFO | 51 | 01/01/2013 | |
Nikola Dimovski
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Miodrag Micajkov
CHM | Chairman | 81 | 01/01/1998 |
| Director/Board Member | 74 | 01/01/1998 | |
| Director/Board Member | - | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 0 | ||
| +1.64% | +3.79% | +35.14% | +201.01% | 95TCr | ||
| +2.61% | +2.65% | +47.63% | +20.53% | 49TCr | ||
| -0.02% | -0.06% | +25.62% | +44.55% | 39TCr | ||
| +0.50% | +5.22% | +29.29% | +18.53% | 36TCr | ||
| -0.68% | +5.50% | +30.47% | +23.34% | 30TCr | ||
| -1.21% | +1.63% | +10.02% | -2.31% | 27TCr | ||
| -0.18% | +4.92% | +25.39% | +35.33% | 27TCr | ||
| -0.62% | +9.33% | -38.17% | -17.02% | 26TCr | ||
| -0.17% | +1.50% | +24.14% | +20.16% | 18TCr | ||
| Average | -0.02% | +4.27% | +21.06% | +38.24% | 34.79TCr | |
| Weighted average by Cap. | +0.38% | +3.97% | +25.98% | +69.14% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 1.65TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.83TCr 47Cr 287.6Cr 113.05Cr 1.35TCr 117.58Cr 115.16Cr 4.96TCr | 1.9TCr 36Cr 31Cr 29Cr 27Cr 50Cr 3.25TCr 54Cr 331.02Cr 130.12Cr 1.56TCr 135.32Cr 132.55Cr 5.7TCr |
| Net income | 157.69Cr 2.99Cr 2.56Cr 2.38Cr 2.22Cr 4.15Cr 269.84Cr 4.45Cr 27Cr 11Cr 129.09Cr 11Cr 11Cr 473.33Cr | 168.4Cr 3.2Cr 2.74Cr 2.55Cr 2.37Cr 4.44Cr 288.18Cr 4.76Cr 29Cr 12Cr 137.86Cr 12Cr 12Cr 505.49Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Equities
- ALK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















